Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.
Cell Line, Tumor
Gene Expression
/ genetics
Gene Expression Profiling
/ methods
Gene Expression Regulation, Leukemic
/ genetics
Gene Rearrangement
/ genetics
Glycomics
/ methods
Histone-Lysine N-Methyltransferase
/ genetics
Humans
Leukemia, Biphenotypic, Acute
/ genetics
Oncogene Proteins, Fusion
/ genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
/ genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/ genetics
Proteomics
/ methods
Transcriptome
/ genetics
Glycomics
Leukemia
Proteomics
Transcriptomics
multi-omics
Journal
Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395
Informations de publication
Date de publication:
2021
2021
Historique:
received:
27
07
2021
accepted:
03
09
2021
entrez:
14
10
2021
pubmed:
15
10
2021
medline:
8
2
2022
Statut:
epublish
Résumé
B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with mixed-lineage leukemia gene rearrangement (MLL-r) is a poor-prognosis subtype for which additional therapeutic targets are urgently needed. Currently no multi-
Identifiants
pubmed: 34646384
doi: 10.7150/thno.65398
pii: thnov11p9519
pmc: PMC8490503
doi:
Substances chimiques
Oncogene Proteins, Fusion
0
Histone-Lysine N-Methyltransferase
EC 2.1.1.43
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9519-9537Subventions
Organisme : NCI NIH HHS
ID : R01 CA236399
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK124116
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA214965
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA211614
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA233691
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA243386
Pays : United States
Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.
Références
Mol Cell Proteomics. 2011 Nov;10(11):M111.009001
pubmed: 21859949
Front Endocrinol (Lausanne). 2014 Oct 27;5:183
pubmed: 25386167
J Clin Oncol. 1998 Dec;16(12):3768-73
pubmed: 9850020
Haematologica. 2020 Apr;105(4):888-894
pubmed: 32139434
Leukemia. 2003 Jan;17(1):175-84
pubmed: 12529676
Front Immunol. 2018 Dec 14;9:2857
pubmed: 30619255
Leukemia. 2008 Jan;22(1):66-77
pubmed: 17851551
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11163-8
pubmed: 11562482
Cell Chem Biol. 2019 Apr 18;26(4):535-547.e4
pubmed: 30745240
Glycobiology. 2019 May 1;29(5):349-354
pubmed: 30778580
Mol Syst Biol. 2018 Nov 20;14(11):e8486
pubmed: 30459171
Nat Commun. 2019 Jun 26;10(1):2803
pubmed: 31243293
Br J Haematol. 2018 Jun;181(5):653-663
pubmed: 29808917
Glycobiology. 2018 Apr 1;28(4):214-222
pubmed: 29390058
Blood. 2011 Jun 9;117(23):6267-76
pubmed: 21487112
Gene. 2016 Feb 10;577(1):1-7
pubmed: 26611529
Glycobiology. 2014 May;24(5):402-6
pubmed: 24653214
Cells. 2020 Dec 21;9(12):
pubmed: 33371192
Glycoconj J. 2017 Jun;34(3):377-391
pubmed: 28577070
Biochem Pharmacol. 2018 Jan;147:183-190
pubmed: 28943239
J Biol Chem. 2019 Jan 25;294(4):1363-1379
pubmed: 30523150
Cancer Cell. 2016 Jul 11;30(1):43-58
pubmed: 27344946
Glycobiology. 2019 Aug 20;29(9):620-624
pubmed: 31184695
Glycobiology. 2015 Dec;25(12):1323-4
pubmed: 26543186
Nat Methods. 2018 Nov;15(11):881-888
pubmed: 30104636
Oncotarget. 2016 Jun 7;7(23):35478-89
pubmed: 27007155
Anal Biochem. 1984 Apr;138(1):141-3
pubmed: 6731838
J Exp Med. 2013 Apr 8;210(4):805-19
pubmed: 23478187
Biochem Biophys Res Commun. 2019 Feb 26;510(1):128-134
pubmed: 30683310
Nucleic Acids Res. 2016 Jan 4;44(D1):D917-24
pubmed: 26507857
Blood. 2013 Mar 7;121(10):1814-8
pubmed: 23319569
Glycobiology. 2012 Jun;22(6):736-56
pubmed: 22183981
Annu Rev Pathol. 2015;10:473-510
pubmed: 25621663
J Biol Chem. 2018 May 11;293(19):7300-7314
pubmed: 29593094
Semin Cell Dev Biol. 2010 Aug;21(6):609-15
pubmed: 20206280
J Clin Oncol. 2010 May 20;28(15):2529-37
pubmed: 20406941
Adv Biol Regul. 2019 Jan;71:41-54
pubmed: 30245264
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Trends Biochem Sci. 2017 Apr;42(4):255-273
pubmed: 27986367
Cell Death Differ. 2013 Aug;20(8):976-86
pubmed: 23703323
Front Immunol. 2018 Dec 04;9:2839
pubmed: 30564237
Blood. 2006 Jul 15;108(2):441-51
pubmed: 16556894
Leuk Res. 1994 Nov;18(11):837-42
pubmed: 7967710
Mol Cell Proteomics. 2017 Apr;16(4):524-536
pubmed: 28122943
Cell. 2017 Feb 23;168(5):890-903.e15
pubmed: 28162770
Biomed Chromatogr. 2001 Oct;15(6):413-7
pubmed: 11559927
Mol Cancer Res. 2016 Dec;14(12):1288-1299
pubmed: 27655130
Glycobiology. 2016 Sep;26(9):907-910
pubmed: 27654115
Cancer Cell. 2015 Oct 12;28(4):500-514
pubmed: 26461094
Genome Biol. 2014;15(12):554
pubmed: 25476604
Dev Cell. 2019 Jul 1;50(1):57-72.e6
pubmed: 31105009
PLoS One. 2019 Jun 18;14(6):e0217633
pubmed: 31211768
J Proteome Res. 2019 Feb 1;18(2):664-677
pubmed: 30574787
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195686
Science. 2020 Jan 31;367(6477):586-590
pubmed: 32001657
Leukemia. 2019 Jul;33(7):1557-1569
pubmed: 30635633
EBioMedicine. 2020 Apr;54:102678
pubmed: 32272438
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16613-8
pubmed: 12464682
Medicines (Basel). 2019 Oct 13;6(4):
pubmed: 31614918
Nat Phys. 2018;14(7):658-669
pubmed: 33859716
Lancet. 2008 Mar 22;371(9617):1030-43
pubmed: 18358930
Glycobiology. 2015 Jan;25(1):55-65
pubmed: 25155433
Biochim Biophys Acta. 2003 Jan 20;1619(2):125-32
pubmed: 12527107
J Biol Chem. 1987 Dec 5;262(34):16343-8
pubmed: 2445746
Nat Rev Nephrol. 2019 Jun;15(6):346-366
pubmed: 30858582
J Exp Clin Cancer Res. 2018 Mar 27;37(1):67
pubmed: 29580262
Oncotarget. 2015 Dec 22;6(41):43529-39
pubmed: 26527314
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
J Biol Chem. 2002 Jan 4;277(1):178-86
pubmed: 11677243
J Proteome Res. 2020 Jan 3;19(1):204-211
pubmed: 31657565
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
PLoS One. 2014 Oct 31;9(10):e110316
pubmed: 25360666
Leukemia. 2018 Feb;32(2):273-284
pubmed: 28701730
Haematologica. 2017 Jan;102(1):118-129
pubmed: 27634205
Leukemia. 2020 Jun;34(6):1540-1552
pubmed: 31919471
Mol Cancer Res. 2021 Apr;19(4):555-564
pubmed: 33472950
Nat Genet. 2019 Feb;51(2):296-307
pubmed: 30643249
Leukemia. 2018 Mar;32(3):633-644
pubmed: 28943635
Leukemia. 1999 Jan;13(1):119-25
pubmed: 10049046
Mol Cell Proteomics. 2013 Apr;12(4):991-5
pubmed: 23378518
Pediatr Blood Cancer. 2016 Jun;63(6):1113-5
pubmed: 26914337
Nat Rev Cancer. 2015 Sep;15(9):540-55
pubmed: 26289314
Biochim Biophys Acta. 2016 Aug;1860(8):1583-95
pubmed: 26987810
Leukemia. 2005 Jun;19(6):953-64
pubmed: 15815718
J Clin Invest. 2012 Oct;122(10):3407-15
pubmed: 23023711
ACS Cent Sci. 2017 Nov 22;3(11):1143-1155
pubmed: 29202016
J Am Chem Soc. 2015 Aug 5;137(30):9685-93
pubmed: 26168351
FEBS Lett. 2018 Dec;592(23):3943-3949
pubmed: 29904918
Front Immunol. 2017 May 24;8:600
pubmed: 28596771
Hum Mol Genet. 2018 Mar 15;27(6):1055-1066
pubmed: 29346549
Expert Rev Mol Med. 2008 Jun 13;10:e17
pubmed: 18549522
Cancer Res. 1991 Feb 15;51(4):1257-63
pubmed: 1997166
Front Med. 2020 Dec;14(6):689-700
pubmed: 33074527
J Allergy Clin Immunol. 2004 Apr;113(4):703-9
pubmed: 15100677
Matrix Biol. 2015 Mar;42:11-55
pubmed: 25701227
Clin Cancer Res. 2010 Apr 1;16(7):2122-30
pubmed: 20332322
EMBO J. 2013 May 15;32(10):1478-88
pubmed: 23584533
PLoS One. 2012;7(9):e43721
pubmed: 22957033
Nat Protoc. 2012 Jun 07;7(7):1299-310
pubmed: 22678433
Glycoconj J. 2018 Apr;35(2):139-160
pubmed: 29680984
Biol Chem. 2018 Jun 27;399(7):649-659
pubmed: 29894293
J Am Soc Mass Spectrom. 2013 Jun;24(6):895-906
pubmed: 23605685
Leukemia. 2008 Apr;22(4):858-61
pubmed: 17851550
J Biol Chem. 2000 Oct 6;275(40):31128-33
pubmed: 10913121
Clin Cancer Res. 2019 Apr 15;25(8):2610-2620
pubmed: 30647079